- Home
- DRVN vs AMRX Comparison
DRVN vs AMRX Comparison
Compare DRVN & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRVN
- AMRX
- Stock Information
- Founded
- DRVN 1972
- AMRX 2002
- Country
- DRVN United States
- AMRX United States
- Employees
- DRVN N/A
- AMRX N/A
- Industry
- DRVN Automotive Aftermarket
- AMRX Biotechnology: Pharmaceutical Preparations
- Sector
- DRVN Consumer Discretionary
- AMRX Health Care
- Exchange
- DRVN Nasdaq
- AMRX Nasdaq
- Market Cap
- DRVN 2.6B
- AMRX 2.5B
- IPO Year
- DRVN 2021
- AMRX N/A
- Fundamental
- Price
- DRVN $16.29
- AMRX $7.78
- Analyst Decision
- DRVN Buy
- AMRX Strong Buy
- Analyst Count
- DRVN 12
- AMRX 5
- Target Price
- DRVN $17.88
- AMRX $10.00
- AVG Volume (30 Days)
- DRVN 568.3K
- AMRX 1.1M
- Earning Date
- DRVN 02-20-2025
- AMRX 11-08-2024
- Dividend Yield
- DRVN N/A
- AMRX N/A
- EPS Growth
- DRVN N/A
- AMRX N/A
- EPS
- DRVN 0.03
- AMRX N/A
- Revenue
- DRVN $2,329,148,000.00
- AMRX $2,680,420,000.00
- Revenue This Year
- DRVN $4.04
- AMRX $17.86
- Revenue Next Year
- DRVN $7.93
- AMRX $3.90
- P/E Ratio
- DRVN $561.80
- AMRX N/A
- Revenue Growth
- DRVN 1.71
- AMRX 12.32
- 52 Week Low
- DRVN $10.59
- AMRX $5.01
- 52 Week High
- DRVN $17.45
- AMRX $9.48
- Technical
- Relative Strength Index (RSI)
- DRVN 50.71
- AMRX 40.38
- Support Level
- DRVN $15.71
- AMRX $7.64
- Resistance Level
- DRVN $17.01
- AMRX $7.86
- Average True Range (ATR)
- DRVN 0.45
- AMRX 0.26
- MACD
- DRVN -0.11
- AMRX -0.01
- Stochastic Oscillator
- DRVN 41.19
- AMRX 26.47
About DRVN Driven Brands Holdings Inc.
Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.